Complement activation and disease: protective effects of hyperbilirubinaemia. - Wikidata - awgldk - TriplyDB

Complement activation and disease: protective effects of hyperbilirubinaemia.

Complement activation and disease: protective effects of hyperbilirubinaemia.

http://www.wikidata.org/entity/Q37609484

about

Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy A review on hemeoxygenase-2: focus on cellular protection and oxygen response Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes.High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases Evaluating the beneficial and detrimental effects of bile pigments in early and later life Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.The effect of sample storage on the Peroxidation of Leukocytes Index Ratio (PLIR) measure.The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling.The molecular basis of jaundice: An old symptom revisited.A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors.Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese.Physiological concentrations of unconjugated bilirubin prevent oxidative stress-induced hepatocanalicular dysfunction and cholestasis.Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome.Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease.Antioxidant and anticomplement functions of flavonoids extracted from Penthorum chinense Pursh.Decreased Serum Bilirubin Levels and Increased Uric Acid Levels are Associated with Ulcerative Colitis

P2860

Q26744708-0E0EF8EF-84DE-4984-BDFE-9B038D16E60D Q27027097-AA6EB3C8-2CEC-44AB-9721-8A44DB196B1D Q30365836-530FCE65-D24D-48BB-A5B8-1FB78DD0AFE1 Q33597289-99FB3B90-7E74-42D9-B78F-FE25B65F1F03 Q34251591-72FBBFDA-93A9-414A-99A5-BFACCFF10DA9 Q35867073-FA001E58-D7DC-4F39-9798-BC71F023567C Q36052685-EB5B8752-7261-4881-A2DE-B286BBD778F1 Q37693865-175915E8-13FB-428D-8476-8B2B3F0563C7 Q37734891-D4C8080A-EF29-4CF3-AE31-2B3AD92C5588 Q37860225-50478A12-08C4-42B4-BC7B-26A3675B5965 Q38206770-211F6F1A-D213-4E22-8D46-E3D8EE5C365D Q38424367-44859107-BFFC-4209-A710-0319DEC5BD14 Q38996518-FE473CF1-42E7-4484-8723-8117D83F7FFE Q39048488-8D548496-FCBA-4A08-832D-55C8B2833F3B Q39813072-67B6875E-2391-4F67-8DA3-E41084A42F51 Q39985398-1CBDBA2F-246B-4F86-88AD-3E43A5922F5B Q42708069-DFF7AB3E-1A06-43ED-8765-6CD2BD96B9EE Q46626565-619A4592-1D18-4DE7-A67A-3251FB9771D2 Q49166468-F3A093B1-2488-4DA1-8AB3-2715F533F310 Q51148954-78DB537B-FCF2-41A4-94E0-FBA8A54D2025 Q58757224-72365925-3998-4653-B0B0-83A566AA3E2E

P2860

Complement activation and disease: protective effects of hyperbilirubinaemia.

http://www.wikidata.org/entity/Q37609484

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Complement activation and disease: protective effects of hyperbilirubinaemia.

@en

Complement activation and disease: protective effects of hyperbilirubinaemia.

@nl

type

label

Complement activation and disease: protective effects of hyperbilirubinaemia.

@en

Complement activation and disease: protective effects of hyperbilirubinaemia.

@nl

prefLabel

Complement activation and disease: protective effects of hyperbilirubinaemia.

@en

Complement activation and disease: protective effects of hyperbilirubinaemia.

@nl

P1433

Q37609484-D882C472-316E-491C-9A23-55229EDB29D5

P1476

Q37609484-A89A0D28-4551-4C70-9DA6-8FC6B92A684B

P2093

Q37609484-102115CD-541D-4C84-BE83-253F9CEB7EA5

Q37609484-14D91F36-B713-4F58-B760-12A0F20D5F5C

Q37609484-1A68CFEE-A81A-4BF2-B9C3-A7E4DA486ABF

Q37609484-BE5EB887-BE83-47D5-9FCE-9C762C2C3789

Q37609484-D09DD0CD-66FF-45AA-8111-B8CD9D49A5C8

Q37609484-E94FA1B7-DD1F-461D-9592-0A3AD96E1D7C

P2860

Q37609484-01E88E13-1970-49E0-A79C-DE255B3C3C1A

Q37609484-0485B842-7B2D-49E9-A545-AF3E38CEB0A0

Q37609484-0A9E66F3-A0BA-4413-B376-B82C2C8C0AE6

Q37609484-14DE1DCC-F25A-47E9-9FC7-423F9B490860

Q37609484-159FD186-519C-40B4-AC40-B1C685F89D09

Q37609484-19BACFBA-415B-4D99-984D-492A5E82F7FD

Q37609484-19BDDE81-A033-41A8-A83E-C87F7F74F3DB

Q37609484-1E339191-1EE1-4C85-8C0F-A9506BA6B68B

Q37609484-20E9255C-CC0D-4512-9AF4-8316D79E76BF

Q37609484-210E71B1-0BD3-4052-9D85-47A3210C25D1

P304

Q37609484-4AC7B47F-DFB7-49D0-857D-899CDBD33D8F

P31

Q37609484-9F66FB88-7EC7-4AFD-AD5A-8279F2C3A810

P356

Q37609484-E47BC8B9-C5FB-490E-A623-0FA52EF6A67F

P407

Q37609484-058BCC9F-E3CC-45EC-918B-A8743FB3B491

P433

Q37609484-B69372A1-8AD4-43E6-A25A-C7CBD0A8C34D

P478

Q37609484-376A21E2-B9D4-41CA-85D7-C7FBC00E8817

P577

Q37609484-AF3205D8-1383-4B2C-8DA2-3BC049A80C05

P698

Q37609484-CF4313E8-D087-4A44-9201-23994851F1AB

P921

Q37609484-3DED3944-EC6B-499D-BD1D-EED8814CDC3C

P356

P1433

Clinical Science

P1476

Complement activation and disease: protective effects of hyperbilirubinaemia.

@en

P2093

Adriana M Almará

http://www.w3.org/2001/XMLSchema#string

Aldo D Mottino

http://www.w3.org/2001/XMLSchema#string

Cecilia L Basiglio

http://www.w3.org/2001/XMLSchema#string

Fabián Pelusa

http://www.w3.org/2001/XMLSchema#string

Jaime Kapitulnik

http://www.w3.org/2001/XMLSchema#string

Sandra M Arriaga

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

Complement. First of two parts

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Bilirubin is an antioxidant of possible physiological importance

Molecular organization and function of the complement system

Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins

Immunology of hepatitis B virus and hepatitis C virus infection

Bilirubin toxicity in the developing nervous system.

Structure and activation of the C1 complex of complement: unraveling the puzzle.

P304

99-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20080540

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19807696

http://www.w3.org/2001/XMLSchema#string

P921

bilirubin metabolic disorder